Video Experimental Relacionado
Updated: Sep 10, 2025

08:56
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
5.5K
Revitalizar el ecosistema biomédico de Japón: iniciativas políticas, desafíos y direcciones futuras
1College of International Management, Ritsumeikan Asia Pacific University, Beppu, Oita, Japan.
Drug discoveries & therapeutics
|August 24, 2025
Resumen
Japón
Área de la Ciencia:
- Innovación biomédica
- Economía de la salud
- La política de innovación
Sus antecedentes:
- La competitividad internacional de Japón en la innovación biomédica está disminuyendo, como lo demuestra un creciente déficit comercial de productos farmacéuticos.
- El ecosistema para traducir la investigación académica en productos y negocios biomédicos comerciales tiene un rendimiento deficiente.
- Los ecosistemas biomédicos existentes en Japón a menudo son de pequeña escala, impulsados por el gobierno y carecen de vías de comercialización efectivas.
Objetivo del estudio:
- Revisar el estado y las características actuales de los ecosistemas de innovación biomédica de Japón.
- Analizar las recientes medidas políticas del gobierno japonés destinadas a revitalizar estos ecosistemas y fomentar la bioeconomía.
- Identificar los desafíos y discutir las direcciones futuras para fortalecer el panorama de innovación biomédica y de descubrimiento de fármacos de Japón.
Principales métodos:
- Revisión de los ecosistemas biomédicos existentes establecidos en los últimos 25 años.
- El análisis de las iniciativas políticas del gobierno japonés se centró en la innovación biomédica y la expansión de la bioeconomía.
- Examen de estrategias para mejorar el ecosistema de descubrimiento de fármacos, incluida la atracción de talentos y empresas.
Principales resultados:
- Japón tiene varios ecosistemas biomédicos, en su mayoría de pequeña escala, a menudo iniciados por el gobierno.
- Las políticas gubernamentales recientes tienen como objetivo crear comunidades biológicas más grandes y expandir la bioeconomía.
- Las nuevas iniciativas se centran en atraer talento y empresas internacionales para impulsar el sector del descubrimiento de fármacos.
Conclusiones:
- El ecosistema de innovación biomédica de Japón se enfrenta a desafíos significativos que afectan su competitividad global.
- Las iniciativas dirigidas por el gobierno están intentando revitalizar el sector y promover la comercialización.
- El éxito futuro depende de abordar eficazmente las debilidades del ecosistema y atraer recursos globales.
Videos de Conceptos Relacionados
Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Whole Body Regeneration
3.4K
Regeneration is the process of restoring injured or lost tissues, organs, or body parts. While simpler organisms generally show greater ability to regenerate their whole body, few complex animals show similarly exceptional regeneration. For example, planarian flatworms have a unique regenerative potential making them a popular study organism among biologists to understand the mechanisms of whole body regeneration. Other organisms, such as hydra, also show extreme regeneration potential;...
3.4K
Bioremediation
20.0K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
20.0K
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

